Team Grant: Intervention Trial in Inflammation for Chronic Conditions

Building on the shared framework for inflammation research initiated through prior CIHR investments (Health Challenge in Chronic Inflammation Phase 1 [HCCI1]), the second phase of HCCI (HCCI2) comprises two distinct funding opportunities that together will accelerate the clinical translation of solutions that target shared pathways of inflammation in chronic conditions. The first component of the HCCI2 initiative, Preparation to Trial (funded in 2021), is supporting the advancement of preclinical research towards the human intervention trial stage and a better understanding of the implementation context to enable the scale up of existing interventions. The current funding opportunity represents the second component, which will support intervention trials (see Additional Information) in humans with clinical impact on inflammation in chronic conditions and knowledge mobilization. For a complete program description and application instructions, click here. Developmental grants of up to $20,000 per grant are available to successful applications at the Letter of Intent (LOI) stage. At the full application stage, a maximum amount per grant of $500,000/  year for up to 4 years, for a total of $2,000,000 per grant.